Marshall Islands vs Saint Kitts and Nevis: Protecting minority investors: Ease of shareholder suits index (0-10)
Marshall Islands
80
in 2019
Saint Kitts and Nevis
80
in 2019
Marshall Islands rank
24th
Saint Kitts and Nevis rank
24th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Marshall Islands
- Saint Kitts and Nevis
How they compare
Marshall Islands currently reports 80 against 80 in Saint Kitts and Nevis, a difference of 0.
Across all 7 years both countries report, Saint Kitts and Nevis has been ahead every year.
Marshall Islands ranks 24th and Saint Kitts and Nevis ranks 24th of 191 countries.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Marshall Islands or Saint Kitts and Nevis?
- Marshall Islands, at 80 against 80 in Saint Kitts and Nevis as of 2019.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Marshall Islands and Saint Kitts and Nevis?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Saint Kitts and Nevis?
- 7 years are reported by both, from 2013 to 2019.
- How do Marshall Islands and Saint Kitts and Nevis rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Marshall Islands ranks 24th and Saint Kitts and Nevis ranks 24th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.